Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Irish Pharmaceutical Healthcare Association naming Colm Burke .
Filed returns
19
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | EU Presidency Associated event with Commission VarHelyi on European Competitiveness and the role of Life Sciences and the Pharmaceutical Industry. (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | Access to medicines in Ireland (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | Irish Pharmaceutical Healthcare Association | Health | Number of Clinical Trials in Ireland (Public policy or programme) | 16 | On lobbying.ie |
| Jan–Apr 2026 | Irish Pharmaceutical Healthcare Association | Health | Moving Codeine containing OTC medicines from pharmacy only to prescription. (Public policy or programme) | 17 | On lobbying.ie |
| Sep–Dec 2025 | Irish Pharmaceutical Healthcare Association | Health | Moving Codeine containing OTC medicines from pharmacy only to prescription. (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2025 | Irish Pharmaceutical Healthcare Association | Health | Future Framework Agreement - issues concerning timely reimbursement of medicines in Ireland. (Public policy or programme) | 10 | On lobbying.ie |
| Jan–Apr 2024 | Irish Pharmaceutical Healthcare Association | Health | (1) Budget 2024 - the need for funding of new medicines. (2) Likely no provision for new developments funding to HSE for new medicines in Budget 2024. (3) Absence of funding for new medicines in Budget 2024. (4)… (Matters involving public funds) | 34 | On lobbying.ie |
| Sep–Dec 2023 | Irish Pharmaceutical Healthcare Association | Health | (1) Reimbursement process improvements under consideration in the Mazar's Working Group. (2) Delays within Medicines Reimbursement System. (3) Preparation for negotiation of a Framework Agreement in 2025. (4) Process… (Public policy or programme) | 16 | On lobbying.ie |
| Sep–Dec 2022 | Irish Pharmaceutical Healthcare Association | Health | EU Policy matters and fast access for new and innovative medicines. (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2021 | Irish Pharmaceutical Healthcare Association | Health | Access to new medicines & new supply agreement (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Access to new medicines (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Extension of framework agreement on medicines. (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2019 | Irish Pharmaceutical Healthcare Association | Health | PwC report for EFPIA on value of pharmaceutical industry (Public policy or programme) | 11 | On lobbying.ie |
| Jan–Apr 2019 | Irish Pharmaceutical Healthcare Association | Health | IPHA policy document "Manifesto for Better Health" (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2018 | Irish Pharmaceutical Healthcare Association | Health | To advise the Fianna Fail Spokesperson on Health and members of the joint Oireachtas Committee on Health of IPHA concerns on a private members bill to amend the Health (Pricing and Supply of Medical Goods) Act 2013 (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2017 | Irish Pharmaceutical Healthcare Association | Health | To challenge claims made in the Sunday Business Post about the effectiveness of some oncology medicines (Public policy or programme) | 17 | On lobbying.ie |
| Jan–Apr 2017 | Irish Pharmaceutical Healthcare Association | Health | The operation of the Framework Agreement and policy issues such as pricing, reimbursement, early access schemes and transparency (Public policy or programme) | 13 | On lobbying.ie |
| Sep–Dec 2016 | Irish Pharmaceutical Healthcare Association | Health | To advise the Fianna Fail Spokesperson on Health and members of the joint Oireachtas Committee on Health of IPHA concerns on a private members bill to amend the Health (Pricing and Supply of Medical Goods) Act 2013 (Public policy or programme) | 11 | On lobbying.ie |
| Sep–Dec 2015 | Irish Pharmaceutical Healthcare Association | Health | Report of Oireachtas Committee on Health and Children on the cost of prescription drugs (Public policy or programme) | 22 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 19 | 100.0% |